Chairs	Shigeki Kuzuhara	President, Japanese Society of Neurology/Professor, Department of Medical Welfare, Suzuka University of Medical Science, Japan/Professor Emeritus (Neurology), Mie University School of Medicine, Japan
	Shoji Tsuji	Department of Neurology, Graduate School of Medicine, The University of Tokyo
Speakers	Ichizo Nishino	National Center of Neurology and Psychiatry
	Miho Murata	National Center of Neurology and Psychiatry

"Breakthrough toward Conquering Neurodegenerative Diseases"

Chair	Ichiro Kanazawa	President, Science Council of Japan
Speaker	Shoji Tsuji	Department of Neurology, Graduate School of Medicine, The University of Tokyo

"World Neurology:Challenges, Opportunities and Priorities"

Chair	Shigeki Kuzuhara	President, Japanese Society of Neurology/Professor, Department of Medical Welfare, Suzuka University of Medical Science, Japan/Professor Emeritus (Neurology), Mie University School of Medicine, Japan
Speaker	Vladimir Hachinski	University of Western Ontario, Canada

Education Program 1

Chair	Yasuhiro Hasegawa	St. Marianna University, School of Medicine
Speaker	Kazumi Kimura	Kawasaki Medical School, Stroke medicine

Education Program 2

Chair	Tomohiko Mizutani	Division of Neurology, Department of Medicine, Nihon University
Speaker	Makoto Iwata	Professor Emeritus, Tokyo Women’s Medical University

Education Program 3

Chair	Takeshi Tabira	Department of Diagnosis, Prevention and Treatment of Dementia, Juntendo University
Speaker	Junichi Kira	Department of Neurology, Kyushu University Graduate School of Medicine

Education Program 4  

Chair	Susumu Kusunoki	Kinki University School of Medicine
Speaker	Satoshi Kuwabara	Department of Neurology, Graduate School of Medicine, Chiba University

Education Program 5

Chair	Yasuto Itoyama	Department of Neurology, Tohoku University School of Medicine
Speaker	Hidehiro Mizusawa	Center for Brain Integration Research, Tokyo Medical and Dental University

Education Program 6  

Chair	Hiroshi Shibasaki	Advisor, Takeda Hospital
Speaker	Yoshikazu Ugawa	Department of Neurology, Fukushima Medical University

Hot Topics 1

Chair	Norihiro Suzuki	Department of Neurology, Keio University Hospital
Speaker	Yukito Shinohara	Tachikawa Hospital

Hot Topics 2  

Chair	Masashi Aoki	Department of Neurology, Tohoku University School of Medicine
Speaker	Jun Goto	Department of Neurology, Graduate School of Medicine, The University of Tokyo

Hot Topics 3

Chair	Atsuro Tiba	Kyorin University
Speaker	Keiko Tanaka	Department of Neurology, Kanazawa Medical University

Hot Topics 4  

Chair	Shinichiro Uchiyama	Department of Neurology, Tokyo Women's Medical University
Speaker	Takaomi Taira	Department of Neurosurgery, Tokyo Women’s Medical University

Hot Topics 5

Chair	Imaharu Nakano	Jichi Medical University Neurology
Speaker	Kenji Ishii	PET Center, Tokyo Metropolitan Institute of Gerontology

Hot Topics 6

Chair	Katsuyuki Sakai	Department of Cognitive Neuroscience, The University of Tokyo
Speaker	Yukiyasu Kamitani	ATR Computational Neuroscience Laboratories

Hot Topics 7  

Chair	Hidenao Fukuyama	Human Brain Research Center, Graduate School of Medicine, Kyoto University
Speaker	Kiyoto Kasai	Neuropsychiatry Faculty of Medicine University of Tokyo

1  "Large-scale Clinical Trials in Neurology"

Chairs	Gen Sobue	Department of Neurology, Nagoya University Graduate School of Medicine
	Hiroshi Mitsumoto	Department of Neurology, Columbia University Medical Center

SY01-1 Disease-modifying Therapies in PD

	Olivier Rascol	Department of Clinical Pharmacology and Neurosciences, INSERM U825, and Clinical Investigation Center, University Hospital, Toulouse, France

SY01-2 Results of the Cilostazol Stroke Prevention Study II

	Shinichiro Uchiyama	Department of Neurology, Tokyo Women's Medical University

SY01-3 Clinical Trials in AD

	Rachelle S. Doody	Department of Neurology, Baylor College of Medicine, USA

SY01-4 Familial Amyloid Polyneuropathy:Diflunisal

	Yoshiki Sekijima	Division of Clinical and Molecular Genetics, Shinshu University Hospital

2  "Academia-based Development of Disease-modifying Therapy"

Chairs	Shu-ichi Ikeda	Department of Medicine(Neurology and Rheumatology), Shinshu University School of Medicine
	Atsushi Iwata	Graduate School of Medicine, Department of Molecular Neuroscience on Neurodegeneration, Tokyo University

SY02-1 Aβ42 Trimer DNA Vaccination is Effective and Safe as a Potential Treatment Therapy for Early Alzheimer's Disease

	Roger N. Rosenberg	Department of Neurology and the Alzheimer’s Disease Center, University of Texas Southwestern Medical Center Dallas

SY02-2 Molecular-targeted Therapy for Spinal and Bulbar Muscular Atrophy (SBMA)

	Gen Sobue	Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan

SY02-3 Gene Therapy Starts to Tackle CNS Disease

	Patrick Aubourg	Department of Pediatric Neurology, Hôpital Saint-Vincent de Paul

SY02-4 Antisense Oligos for Muscular Dystrophy

	Tetsuya Nagata	National Institute of Neuroscience, National Center of Neurology and Psychiatry

SY02-5 Therapeutic Approaches for Patients with Adult-onset type II Citrullinemia-Effectiveness of Treatment with Low-carbohydrate Diet and Sodium Pyruvate

	Masahide Yazaki	Department of Neurology and Rheumatology, Shinshu University School of Medicine

3  "Overcoming Intractable Neurologic Diseases －Approaches to Single Gene Diseases—"

Chairs	Ｈidehiro Ｍizusawa	Center for Brain Integration Research, Tokyo Medical and Dental University
	Shoji Tsuji	Department of Neurology, Graduate School of Medicine, The University of Tokyo

SY03-1 CARASIL- Formulation of the Clinical Concept-

	Toshio Fukutake	Department of Neurology Kameda Medical Center

SY03-2 Molecular Mechanism and Therapeutic Strategy for Cerebral Small Vessel Disease

	Kenju Hara	Department of Neurology, Akita Red Cross Hospital

SY03-3 Familial Wernicke's Encephalopathy

	Hiroaki Miyajima	Department of Medicine, Hamamatsu University School of Medicine

SY03-4 Spinocerebellar Ataxia Type 6: from Genetics to Therapeutic Strategies

	Kei Watase	Center for Brain Integration Research, Tokyo Medical and Dental University

SY03-5 Amyotrophic Lateral Sclerosis Associated with Mutations in the Sod1 Gene

	Masashi Aoki	Department of Neurology, Tohoku University School of Medicine

4  "Breakthrough in the Molecular Pathogenesis of Parkinson's Disease"

Chairs	Ryosuke Takahashi	Kyoto University Hospital
	Masanori Nakagawa	Department of Neurology and Gerontology, Kyoto Prefectural University of Medicine

SY04-1 Molecular Genetics of Familial Parkinson's Disease

	Nobutaka Hattori	Department of Neurology, Juntendo University School of Medicine

SY04-2 Susceptibility Genes for Sporadic Parkinson's Disease: Common Disease-Common Variants

	Tatsushi Toda	Division of Neurology, Kobe University Graduate School of Medicine

SY04-3 Genetic Basis of Sporadic Parkinson Disease: Common Disease-Multiple Rare Variants

	Jun Mitsui	Department of Neurology, University of Tokyo, Graduate School of Medicine

SY04-4 Mechanisms Underling the Cause of Parkinson's Disease: The Functions of Parkin/Pink1

	Keiji Tanaka	Tokyo Metropolitan Institute of Medical Science

5  "Glia in CNS Immunopathology"

Chairs	Akio Suzumura	Department of Neuroimmunology, RIEM, Nagoya University
	Susumu Kusunoki	Department of Neurology, Kinki University School of Medicine

SY05-1 Promoting Remyelination by Reducing an Inhibitory Microenvironment

	V. Wee Yong	University of Calgary, Canada

SY05-2 Blueprint for the Development of Remyelination Medicines for Multiple Sclerosis

	Jin Nakahara	Center for Integrated Medical Research ＆ Department of Neurology, Keio University School of Medicine

SY05-3 Microglia and Neuronal Degeneration

	Akio Suzumura	Department of Neuroimmunology, RIEM, Nagoya University

SY05-4 Pathogenesis of Neuromyelitis Optica:aquaporin 4 autoimmunity and astrocytopathy

	Tatsuro Misu	Department of Neurology, Tohoku University School of Medicine

SY05-5 Humoral and Cellular Immune Responses in Neuromyelitis Optica

	Izumi Kawachi	Department of Neurology, Brain Research Institute, Niigata University

6  "Treating Cerebrovascular Diseases:A quest for the next breakthrough"

Chairs	Shinichi Takahashi	Department of Neurology, Keio University School of Medicine
	Gregory J. del Zoppo	Departments of Medicine and Neurology, University of Washington School of Medicine, USA

SY06-1 Regulating the Responses of the Neurovascular Unit to Focal Ischemia

	Gregory J. Del Zoppo	Departments of Medicine and Neurology University of Washington Seattle, Washington USA

SY06-2 Role of T lymphocytes in Ischemic Brain Injury

	Takashi Shichida	Department of Microbiology and Immunology, School of Medicine, Keio University

SY06-3 Progression of Brain Infarction and Endoplasmic Reticulum(ER)-stress

	Hideaki Hara	Molecular Pharmacology, Gifu Pharmaceutical University

SY06-4 Immunomodulation by Inducing Tolerance to E-selectin and Adult Neurogenesis after Stroke

	Satoru Ishibashi	Department of Neurology and Neurological Science, Tokyo Medical and Dental University

7  "The Forefront of Regenerative Medicine Research"

Chairs	Haruhisa Inoue	Institute for Integrated Cell-Material Sciences(iCeMS), Kyoto University
	Hideyuki Okano	Department of Physiology, Keio University School of Medicine

SY07-1 Investigation of Regeneration of Damaged CNS and Neurological Diseases Mechanisms

	Hideyuki Okano	Dept. of Physiology, Keio University School of Medicine

SY07-2 Migration of New Neurons towards the Injured Brain Tissue

	Kazunobu Sawamoto	Department of Developmental and Regenerative Biology, Nagoya City University Graduate School of Medical Sciences

SY07-3 Derivation of Engraftable Myogenic Precursors from Murine ES/iPS cells and Generation of Disease-specific iPS cells from Patients with Duchenne Muscular dystrophy(DMD)and Other Diseases

	Tatsutoshi Nakahata	Department of Pediatrics, Graduate School of Medicine, Center for iPS Cell Research and Application, Kyoto University

SY07-4 Simple Test for Evaluation the Safeness of Human Induced Pluripotent Stem Cells

	Kazutoshi Takahashi	CiRA, Kyoto University

SY07-5 Opportunities for Neurorestorative Therapies in PD Using iPS and Stem Cells

	Ole Isacson	Director, Center for Neuroregeneration Research, McLean Hospital / Harvard Medical School, USA and NIH Udall Parkinson Disease Research Center of Excellence

8  "Frontlines of the Epilepsy Treatment for Practicing Neurologists"  

Chairs	Tatsuya Tanaka	Yamabiko Medical Welfare Center, International League Against Epilepsy
	Sadatoshi Tsuji	Department of Neurology, University of Occupational and Environmental Health School of Medicine(UOEH)

SY08-1 Why Don’t Medicines for Epilepsy Always Work?

	Edward H. Bertram	Department of Neurology,University of Virginia, USA

SY08-2 Selection of Proper Antiepileptic Drugs

	Sunao Kaneko	Department of Neuropsychiatry, Hirosaki University Graduate School of Medicine

SY08-3 Clinical Characteristics and Treatment for New Onset Epilepsy in the Elderly

	Naoki Akamatsu	Department of Neurology, University of Occupational and Environmental Health School of Medicine

SY08-4 Is the Genetic Diagnosis of Epilepsy Useful in Clinical Practice?

	Shinichi Hirose	Department of Pediatrics, Fukuoka University

9  "New Methods to Study Human Brain Functional Connectivity"  

Chairs	Yoshikazu Ugawa	Fukushima Medical University
	Hidenao Fukuyama	Graduate School of Medicine Kyoto University

SY09-1 Connections Among Motor-Related Areas Revealed by Resting-State Functional Connectivity MRI

	Hayashi Toshihiro	The University of Tokyo Hospital

SY09-2

	Isa Tadashi	National Institute for Physiological Sciences

SY09-3 Quadri-Pulse Stimulation (QPS) and Metaplasticity in Humans

	Masashi Hamada	Department of Neurology, the University of Tokyo

SY09-4 Brain Connectivity Studied by Multidimensional Neuroimaging Technique

	Takashi Hanakawa	Dept. of Cortical Function Disorders, National Center of Neurology and Psychiatry

Symposium 10  "New Concept of and Strategy Against TIA"  

Chairs	Shinichiro Uchiyama	Department of Neurology, Tokyo Women’s Medical Universtiy

SY10-1 New Definition and Concept of TIA

	Shinichiro Uchiyama	Department of Neurology, Tokyo Women’s Medical University

SY10-2 The Present Status of Diagnosis and Treatment of TIA in Japan

	Kazuo Minematsu	National Cerebral ＆ Cardiovascular Center

SY10-3 The First Stage Examination and Therapy for Patients with TIA

	Yasushi Okada	National Hospital Organization, Kyushu Medical Organization

SY10-4

	Koji Abe	Department of Neurology, Graduate School of Medicine, Dentistry, and Pharmacological Sciences, Okayama University

11  "Branch Atheromatous Disease (BAD):Clinical Problems and Controversies in Diagnosis and Management"

Chairs	Makoto Takagi	Tokyo Saiseikai Central Hospital

SY11-1 The Concept and Clinical Significance of BAD

	Yasumasa Yamamoto	Kyoto Second Red Cross Hospital

SY11-2 Neuroimaging and Criteria for Diagnosis of BAD

	Yasuo Terayama	Department of Neurology and Gerontology, Iwate Medical University

SY11-3 Clinical Features and Outcomes of Branch Atheromatous Disease - Analysis Results of J-BAD Registry

	Haruhiko Hoshino	Department of Neurology, Keio University School of Medicine

SY11-4 The Treatment of Branch Atheromatous Disease (BAD) - From The Analysis of J-BAD Registry Data

	Hidetaka Takeda	Department of Neurology and Cerebrovascular Medicine, Saitama International Medical Center, Saitama Medical University

12  "Consortia for Clinical Studies on Neurological Diseases"

Chairs	Osamu Onodera	Department of Molecular Neuroscience, Niigata University Brain Research Institute
	Kenji Nakashima	Department of Neurology, Tottori University

SY12-1 Natural History Studies and the EUROSCA Clinical Research Network

	Thomas Klockgether	Department of Neurology, University Hospital Bonn, Germany

SY12-2 Japan Multiple System Atrophy Research Consortium(JAMSAC)

	Yaeko Ichikawa	Department of Neurology, University of Tokyo

SY12-3 Japanese Consortium for Amyotrophic Lateral Sclerosis Research(JaCALS)

	Naoki Atsuta	Department of Neurology, Nagoya University Hospital
	Gen Sobue	Department of Neurology, Nagoya University Graduate School of Medcine

SY12-4 Japan Spastic Paraplegia Research Consortium(JASPAC)

	Yoshihisa Takiyama	Department of Neurology, Interdisciplinary Graduate School of Medicine and Engineering University of Yamanashi

SY12-5 J-ADNI

	Takeshi Iwatsubo	Department of Neuropathology, School of Medicine, University of Tokyo

13  "Research Frontier for TDP-43 and TLS, Pathogenic Proteins for ALS"

Chairs	Nobuyuki Nukina	RIKEN Brain Science Institute
	Masatoyo Nishizawa	Brain Research Institute, Niigata University

SY13-1 The TDP-43 Proteinopathies - Toward an Experimental Animal Model

	Masato Hasegawa	Tokyo Institute of Psychiatry

SY13-2 Clinical and Pathological Features of ALS10

	Osamu Onodera	Department of Molecular Neuroscience, Resource Branch for Brain Disease, Niigata University

SY13-3 Non-Human Primate Model of ALS by Overexpression of TDP-43

	Takanori Yokota	Department of Neurology and Neurological Science, Tokyo Medical and Dental University

SY13-4 FUS/TLS as a Polyglutamine-Aggregate Interacting Protein

	Nobuyuki Nukina	RIKEN Brain Science Institute Lab for Structural Neuropathology

SY13-5 Clinical and Pathological Aspects of ALS- FUS/TLS

	Murayama Shigeo	Department of Neuropathology(the Brain Bank for Aging Research), Tokyo Metropolitan Geriatric Hospital ＆ Institute of Gerontology

14  "Frontline in Neurogenomics"

Chairs	Tatsushi Toda	Division of Neurology, Kobe University Graduate School of Medicine
	Hidenao Sasaki	Department of Neurology, Hokkaido University Graduate School of Medicine

SY14-1 Application of Next Generation Sequencers in Neurogenetics

	Jeffery Vance	Department of Human Genetics, University of Miami, USA

SY14-2 Exploring the Responsible Gene for a Familial ALS by Next-generation Sequencer

	Tadashi Kaname	Department of Medical Genetics, University of the Ryukyus Graduate School of Medicine, Okinawa

SY14-3 Massively Parallel Sequence Analysis for Revealing Causes of Neuromuscular Disorders

	Hiroyuki Ishiura	Department of Neurology, Graduate School of Medicine, The University of Tokyo

15  "Idiopathic Normal Pressure Hydrocephalus (iNPH): Recent Advances in Research on Pathogenesis"

Chairs	Takeo Kato	Yamagata University Hospital
	Tatsuhiko Yuasa	Kamagata General Hospital

SY15-1

	Etsuro Mori	Tohoku University

SY15-2   Epidemiological Study: iNPH and AVIM

	Takeo Kato	Department of Neurology, Hematology, Metabolism, Endocrinology and Diabetology

SY15-3 Understanding of Cerebrospinal Fluid (CSF) Hydrodynamics in Idiopathic Hydrocephalus (A) Visualization of CSF Bulk Flow with MRI Time-Spatial Labeling Pulse Method (time-SLIP)

	Shinya Yamada	Tokai University Oiso Hospital

SY15-4 Glycan Biomarker in CSF

	Yasuhiro Hashimoto	Fukushima Medical University School of Medicine Department of Biochemistry

SY15-5

	Hajime Arai	Juntendo University Hospital

16  "Neurodegenerative Diseases and RNA"

Chairs	Jun Goto	Department of Neurology, Graduate School of Medicine, The University of Tokyo
	Hiroshi Takashima	Department of Neurology and Geriatrics, Kagoshima University

SY16-1 Inefficient A-to-I RNA Editing and ALS

	Shin Kwak	Department of Neurology, Graduate School of Medicine, The University of Tokyo

SY16-2 Implications of microRNA Dysfunction in the Pathogenesis of ALS

	Yukio Kawahara	Lab. of RNA function, Graduate School of Medicine, Osaka University

SY16-3 Double the Trouble:Bidirectional Expression of the SCA8 CAG/CTG Expansion Mutation - Evidence for RNA and Protein Gain of Function Effects

	Laura P.W. Ranum	Department of Genetics, Cell Biology, and Development / Institute of Human Genetics, University of Minnesota, USA

SY16-4 RNA-mediated Disease Mechanism of Spinocerebellar Ataxia Type 10

	Tohru Matsuura	Department of Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

SY16-5 Spinocerebellar Ataxia Type 31

	Kinya Ishikawa	Department of Neurology and Neurological Science, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan

17  "The Molecular Mechanisms for Generation of Pain and its Propagation in Migraine"

Chairs	Norihiro Suzuki	Department of Neurology, Keio University Hospital
	Kenji Nakashima	Faculty of Medicine, Tottori University

SY17-1 The Cause of Pain in Migraine

	Toshihiko Shimizu	Keio University, School of Medicine, Department of Neurology

SY17-2 Chronification of Migraine Headache: Clinical Feature and Mechanism of Chronic Migraine and Medication Overuse Headache

	Takao Takeshima	Tominaga Hospital Neurology, Headache Center

SY17-3

	Junichi Hamada	Kitasato University Hospital

SY17-4 Molecular Genetics of Migraine Applying DNA Microarray-Based Comprehensive Resequencing and High Throughput Linkage Analysis System

	Yuji Takahashi	Department of Neurology, Graduate School of Medicine, The University of Tokyo

18  "Limbic System"

Chairs	Toshio Fukutake	Kameda Medical Center
	Mitsuru Kawamura	Department of Neurology, Showa University School of Medicine

SY18-1 Human Pain and Itch Perception in the Limbic System

	Ryusuke Kakigi	National Institute for Physiological Sciences

SY18-2 Insula and Disgust

	Atsunobu Suzuki	Department of Social and Human Environment, Graduate School of Environmental Studies, Nagoya University

SY18-3 Relation between Limbic System (Especially Amygdala) and Autonomic Nervous System

	Takashi Ueyama	Wakayama Medical University School of Medicine Department of Anatomy and Cell Biology

SY18-4 Orbitofrontal Cortex and Moral

	Masaru Mimura	Showa University

SY18-5

	Mitsuru Kawamura	Department of Neurology, Showa University School of Medicine

19  "A Fresh Look at Dementia Research"

Chairs	Mitsuru Kawamura	Department of Neurology, Showa University School of Medicine
	Thomas H. Bak	University of Edinburgh, UK

SY19-1 Learning from History—FTD, ALS and Behaviour

	Thomas H. Bak	University of Edinburgh, UK

SY19-2 Language in ALS/FTLD

	Hiroo Ichikawa	Department of Neurology, Showa University School of Medicine

SY19-3 Acquired Savant Syndrome in FTD

	Keisuke Takahata	Department of Neuro-Psychiatry Keio University School of Medicine

SY19-4 Clinicopathological Characterization of Sporadic FTLD with TDP-43-positive Inclusions

	Osamu Yokota	Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

SY19-5 FTD/ALS as TDP-43 Proteinopathies

	Tomohiko Ishihara	Department of Neurology, Brain Research Institute, Niigata University / Department of Center for Bioresource-based Researches, Brain Research Institute, Niigata University

20  "Ethics of End of Life Issues in Neurological Diseases"

Chairs	Mieko Ogino	Kitasato University East Hospital
	Masatoyo Nishizawa	Brain Research Institute, Niigata University

SY20-1 The Survey Report about the End-of-Life Care with Als Patients of the ALS Physicians in Japan

	Mieko Ogino	Kitasato University

SY20-2 From the Viewpoint of Clinical Ethics

	Tetsuro Shimizu	Uehiro Endowed Chair for Death and Life Studies, Graduate School of Humanities and Sociology, The University of Tokyo

SY20-3 Law, Judicial Precedent and Guidelines Concerning the End-of-Life is Sues of the Neurological Intractable Diseases

	Kazuto Inaba	Chukyou University

Symposium 21  "How Should We Change the Educational Program of Neurology ?"

Chairs	Teruo Shimizu	Department of Neurology, Teikyo University School of Medicine
	Fumihito Yoshii	Department of Neurology, Tokai University School of Medicine

SY21-1 A New Pathway to Neurology Education in Japan

	Nobuo Yanagisawa	Tokyo University of Technology

SY21-2 How Can Be the Favorable and Effective Instructional Design (ID) for the Future Neurologist ?

	Manabu Doyu	Department of Neurology, Aichi Medical University

SY21-3 Teaching Materials in Integrated Curriculum of Neurology; Development and Sharing

	Itaru Toyoshima	Medical Education Center, Akita University School of Medicine

SY21-4

	Takahiro Amano	Sanno Medical Center

22  "Establishment of Economic Foundation for Clinical Neurologists is Essential for the Advancement of Neurology in Japan"

Chairs	Tetsuya Takayanagi	Professor Emeritus (Neurology), Nara Medical University
	Ryuji Tamura	Tamura Hospital

SY22-1 Development of Medical Insurance in Japanese Neurology

	Tetsuya Takayanagi	Hongo Clinic of Ophthalmology and Neurology

SY22-2 Toward Establishment of the Economical Basis for Medical Care of Neurology in Japan - Appropriate Assessment of Techniques for Diagnosis and Treatments in Neurology

	Norihiro Suzuki	Department of Neurology, Keio University Hospital

SY22-3 Economical Basis for Neurologic Services and the System for Health Insurance: Diagnosis Procedure Combinations and Insurance Scores of Neurophysiological Tests

	Yoshiyuki Kuroiwa	Department of Clinical Neurology and Stroke Medicine Yokohama city University Graduate School of Medical Sciences

SY22-4 Explanation Method about Health Economics Value of Neurology

	Tomoyuki Takura	Osaka University Hospital

23  "How Do We Cure the *Medical Divide* between Tokyo Urban Area and Northern Tohoku Rural Area?"  

Chairs	Hikoaki Fukaura	Iwate Medical University

SY23-1 Analysis of the Shortage of Doctors in Medical University Hospitals in Urban City

	Kazumasa Yokoyama	Department of Neurology Juntendo University School of Medicine

SY23-2 Medical Care for Patients with Neurological Diseases in Aomori

	Masahiko Tomiyama	Department of Neurology, Aomori Prefectural Central Hospital

SY23-3 Medical Circumstances in the Suburbs of Tokyo: The Difference in an Urban Region and Rural Districts

	Takashi Ohashi	Neurology Division, Tokyo Women’s University Yachiyo Medical Center

SY23-4 How Do We Cure the Medical Divide Between Tokyo Urban Area and Northern Tohoku Rural Area?-Medical Circumstances of Patients with Neurological Diseases

	Hikoaki Fukaura	Iwate Medical University, Neurology

"Clinical Pathway Guideline for Stroke in Korea"

Chair	Shigeki Kuzuhara	President, Japanese Society of Neurology Department of Medical Welfare, Suzuka University of Medical Science, Japan Professor Emeritus (Neurology), Mie University School of Medicine, Japan
Speaker	Hee-Joon Bae	Department of Neurology, Stroke Center, Seoul National University Budang Hospital, Seoul National University College of Medicine, Korea

"Acute Stroke Management in Japan"

Chair	Beom S. Jeon	International Delegate, Korean Neurological Association Department of Neurology Seoul National University Hospital, Korea
Speaker	Yasuyuki Iguchi	Department of Stroke Medicine, Kawasaki Medical School, Japan

"Stroke in China—Past, Present and Future"

Chair	Dershin Ke	President, Taiwan Neurological Society Director, Department of Neurology, Chi Mei Medical Center, Taiwan
Speaker	Chuanzhen Lu	Institute of Neurology, Hua Shan Hospital, Fudan University, China Former President of Chinese Neurological Society

"Management and Research of Stroke in Taiwan"

Chair	Chuanzhen Lu	Institute of Neurology, Hua Shan Hospital, Fudan University, China Former President of Chinese Neurological Society
Speaker	Chih-Ping Chung	Section of Cerebrovascular Diseases, Department of Neurology, Taipei Veterans General Hospital, Taiwan